Correlation of hepatitis C RNA and serum alanine aminotransferase in hepatitis B and C seronegative healthy blood donors

Indian Journal of Pathology and Microbiology

Volumn 53, Issue 3, 2010, Pages 486-491

  Ali, Natasha ^a   Moiz, Bushra ^a   Moatter, Tariq ^b   Ahmed, Shiraz ^b   Adil, Salman ^a   Khurshid, Mohammad ^c  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

^b AGA KHAN UNIVERSITY   (Pakistan)

^c AGA KHAN UNIVERSITY MEDICAL COLLEGE   (Pakistan)

Author keywords

HCV RNA; Hepatitis C; serum alanine aminotransferase

Indexed keywords

ALANINE AMINOTRANSFERASE; VIRUS RNA; HEPATITIS ANTIBODY;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD DONOR; CLINICAL LABORATORY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; COST EFFECTIVENESS ANALYSIS; DISEASE MARKER; ERYTHROCYTE; FEMALE; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALARIA; MALE; NONHUMAN; NORMAL HUMAN; OUTCOME ASSESSMENT; PLASMA; POLYMERASE CHAIN REACTION; RANDOMIZED CONTROLLED TRIAL; REFERENCE VALUE; RNA VIRUS; SEROCONVERSION; SEROLOGY; SYPHILIS; TERTIARY HEALTH CARE; THROMBOCYTE; ADOLESCENT; BLOOD; COST BENEFIT ANALYSIS; ECONOMICS; ISOLATION AND PURIFICATION; LIVER FUNCTION TEST; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; ALANINE TRANSAMINASE; BLOOD DONORS; COST-BENEFIT ANALYSIS; FEMALE; HEPACIVIRUS; HEPATITIS ANTIBODIES; HEPATITIS C; HUMANS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; RNA, VIRAL; YOUNG ADULT;

EID: 77955861080     PISSN: 03774929     EISSN: 09745130     Source Type: Journal    
DOI: 10.4103/0377-4929.68284     Document Type: Article

References (28)

1. Ozer J, Ratner M, Shaw M, Bailey W, Schomaker S. The current state of serum biomarkers of hepatotoxicity. Toxicology 2008;245:194-205.
2. Song HR, Yun KE, Park HS. Relation between alanine aminotransferase concentrations and visceral fat accumulation among nondiabetic overweight Korean women. Am J Clin Nutr 2008;88:16-21.
3. Yue M, Ni Q, Yu CH, Ren KM, Chen WX, Li YM. Transient elevation of hepatic enzymes in volunteers after intake of alcohol. Hepatobiliary Pancreat Dis Int 2006;5:52-55
4. Borini P, Guimaraes RC, Borini SB. Possible hepatotoxicity of chronic marijuana usage. Sao Paulo Med J 2004;122:110-116
5. Bhavnani M, Lloyd D, Bhattacharyya A, Marples J, Elton P, Worwood M. Screening for genetic haemochromatosis in blood samples with raised alanine aminotransferase. Gut 2000;46:707-710
6. Zakiah I, Zaini AR, Jamilah B, Zawiah A. Alpha-1-antitrypsin deficiency in babies with prolonged jaundice. Malays J Pathol 1992;14:91-94
7. Khouri ST, Lopes EP, Perez RM, Figueiredo VM, Lanzoni VP, Silva AE, et al. Determination of alanine aminotransferase in blood donor screeningevidence of its usefulness in the prevention of post-transfusion hepatitis. Clin Lab 2004;50:291-294
8. Gretch DR. Diagnostic tests for hepatitis C. Hepatology 1997;26:43S-7S.
9. Busch MP, Korelitz JJ, Kleinman SH, Lee SR, AuBuchon JP, Schreiber GB. Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection: The Retrovirus Epidemiology Donor Study. Transfusion 1995;35:903-910
10. Tuke PW, Grant PR, Waite J, Kitchen AD, Eglin RP, Tedder RS. Hepatitis C virus window-phase infections: Closing the window on hepatitis C virus. Transfusion 2008;48:594-600.
11. Hourfar MK, Jork C, Schottstedt V, Weber-Schehl M, Brixner V, Busch MP, et al. Experience of German Red Cross blood donor services with nucleic acid testing: Results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus. Transfusion 2008;48:1558-1566
12. Kim SM, Lee KS, Park CJ, Lee JY, Kim KH, Park JY, et al. Prevalence of occult HBV infection among subjects with normal serum ALT levels in Korea. J Infect 2007;54:185-191
13. Khokhar N, Gill ML, Malik GJ. General seroprevalence of hepatitis C and hepatitis B virus infections in population. J Coll Physicians Surg Pak 2004;14:534-536 (Pubitemid 39341726)
14. Asif NK, Ilahi F. Seroprevalence of HBV, HCV and HIV infection among voluntary non remunerated and replacement donors in northern Pakistan. Pak J Med Sci 2004;20:24-28
15. Kakepoto GN, Bhally HS, Khaliq G, Kayani N, Burney IA, Siddiqui T, et al. Epidemiology of blood-borne viruses: A study of healthy blood donors in Southern Pakistan. Southeast Asian J Trop Med Public Health 1996;27:703-706
16. Akhtar S, Younus M, Adil S, Jafri SH, Hassan F. Hepatitis C virus infection in asymptomatic male volunteer blood donors in Karachi, Pakistan. J Viral Hepat 2004;11:527-535
17. Gretch DR. Use and interpretation of HCV diagnostic tests in the clinical setting. Clin Liver Dis 1997;1:543-557
18. Ali SA, Donahue RM, Qureshi H, Vermund SH. Hepatitis B and hepatitis C in Pakistan: Prevalence and risk factors. Int J Infect Dis 2009;13:9-19.
19. Akkaya O, Kiyici M, Yilmaz Y, Ulukaya E, Yerci O. Clinical significance of activity of ALT enzyme in patients with hepatitis C virus. World J Gastroenterol 2007;13:5481-5485
20. Krajden M. Hepatitis C virus diagnosis and testing. Can J Public Health 2000;91:S34-9,S6-42.
21. Ali NK, Anwar M. Prevalence of hepatitis b s antigen and hepatitis C antibodies in young healthy adults. Pak J Pathol 2002;13:3-6.
22. Ali SA, Donahue RM, Qureshi H, Vermund SH. Hepatitis B and hepatitis C in Pakistan: Prevalence and risk factors. Int J Infect Dis 2009;13:9-19.
23. Aguelles O, Janot C. Epidemiology of anti-HCV antibodies in France: Viral hepatitis study group of the French blood transfusion society Arch Virol Suppl 1992;4:249-252
24. Notari EP, Orton SL, Cable RG, Grindon AJ, Lenes BA, Williams AE, et al. Seroprevalence of known and putative hepatitis markers in United States blood donors with ALT levels at least 120 IU per L. Transfusion 2001;41:751-755
25. Lee SC, Antony A, Lee N, Leibow J, Yang JQ, Soviero S, et al. Improved version 2.0 qualitative and quantitative AMPLICOR reverse transcription-PCR tests for hepatitis C virus RNA: Calibration to international units, enhanced genotype reactivity, and performance characteristics. J Clin Microbiol 2000;38:4171-4179
26. Mujeeb SA, Pearce MS. Temporal trends in hepatitis B and C infection in family blood donors from interior Sindh, Pakistan. BMC Infect Dis 2008;8:43.
27. Morota K, Fujinami R, Kinukawa H, Machida T, Ohno K, Saegusa H, et al. A new sensitive and automated chemiluminescent microparticle immunoassay for quantitative determination of hepatitis C virus core antigen. J Virol Methods 2009;157:8-14
28. Velati C, Romano L, Fomiatti L, Baruffi L, Zanetti AR. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: A 6-year survey. Transfusion 2008;48:2205-2213